In line with the broader negative trend in overall M&A investment worldwide, the global M&A activity in the life sciences industry experienced a slowdown in 2022: M&A activity declined significantly in both the number and value of deals compared to the previous year. However, there is hope that 2023 will be a more active year … Continue reading Life Sciences M&A Report
